Gracyn J Campbell1, Tim Y Li2, Ranqing Lan1, Ek T Tan1, and Darryl B Sneag1
1Radiology and Imaging, Hospital for Special Surgery, New York, NY, United States, 2Weill Cornell Medical College, New York, NY, United States
Synopsis
Keywords: Muscle, Quantitative Imaging
Motivation: Parsonage-Turner syndrome (PTS) is a spontaneous peripheral neuropathy affecting upper extremity nerves and leading to severe muscle denervation. Quantitative MRI (qMRI) can objectively evaluate the degree of denervation and muscle recovery from PTS over time.
Goal(s): To characterize PTS-related muscle denervation using qMRI biomarkers and to assess longitudinal changes.
Approach: In 21 PTS subjects at up to four timepoints, the associations of T2, apartment fiber diameter (AFD), fat fraction (FF), and muscle volume with electromyography and muscle function were analyzed.
Results: Associations between qMRI biomarkers reflect severity of muscle denervation in PTS. Recovery, involving reduced edema and increased atrophy, may follow non-linear patterns.
Impact: Quantitative MRI biomarkers including T2 mapping, apparent fiber
diameter, fat fraction, and muscle volumetry correlate with electrodiagnostic and
functional assessments of denervation and muscle function impairment in Parsonage-Turner
syndrome (PTS), and they can longitudinally characterize PTS-related changes.
Introduction
Parsonage-Turner syndrome (PTS) is a rare peripheral neuropathy
characterized by spontaneous pain followed by profound weakness in the upper
extremity secondary to muscle denervation1,2. Patterns of disease
progression and recovery from PTS are poorly understood, with patients
typically recovering in 1-2 years and experiencing residual pain and fatigue3,4. Techniques for
obtaining quantitative MRI (qMRI) biomarkers, including T2 mapping, apparent
fiber diameter (AFD), fat fraction (FF), and muscle volumetry can characterize PTS-related
muscle denervation5,6.
Muscle function and motor unit recruitment (MUR) are evaluated by physical exam
and electromyography (EMG), respectively4,7.
This study aimed to: (1) evaluate associations between qMRI biomarkers, (2) evaluate
the relationship among qMRI, muscle function, and EMG in patients with PTS, and
(3) characterize the longitudinal behavior of qMRI biomarkers. We hypothesized
that longitudinal qMRI changes would explain patterns of muscle edema, atrophy,
and fatty infiltration, and would correlate with muscle function and EMG MUR.Methods
Patients
with a clinical diagnosis of PTS (confirmed with EMG) involving the suprascapular nerve (supplying the supraspinatus/infraspinatus muscles) and/or
axillary nerve (supplying the deltoid muscle) provided written, informed consent for
this prospective, IRB-approved study. Subjects were imaged at baseline (within
6 months of symptom onset) and after 3, 6, and 12 months. MRI was performed at
3-Tesla (Signa Premier, GE Healthcare) using a protocol that included a 2D multi-echo-spin-echo
sequence for T2 mapping, multi-shell DTI for AFD, and 3D Dixon gradient echo
for volumetry and fat fraction assessments. Manual segmentations of the
supraspinatus, infraspinatus, deltoid and subscapularis (as a control) muscles were
performed by two independent raters (MeVis Medical Solutions AG (muscle volume);
ITK-Snap (qMRI)). Linear regressions were performed to evaluate associations
between qMRI, EMG, and muscle function (evaluated using the medical research
council (MRC) scale for shoulder abduction and external rotation). A linear mixed
effect model was used to evaluate associations between time from symptom onset
and qMRI biomarkers, with variation between subjects accounted for as a random
effect. Results
A total of 21 subjects (47±15 years-old, 13 men) were included, with 13
subjects completing all 4 timepoints, 6 completing 3, and 2 completing 2
(Figure 1). The intraclass correlation coefficients for inter-rater agreement
of manual muscle segmentations were 0.95-0.99. In PTS-involved
muscles, negative associations were observed between muscle volume and T2, while
positive associations were observed between volume and AFD (Table 1). Associations
between volume and FF were not significant. Associations between EMG MUR severity
and T2 or FF were mostly negative, while associations between MUR and AFD were
mostly positive (Table 2). Similarly, associations between MRC scores and qMRI
metrics followed expected polarity (Table 2). Longitudinal analysis showed significant
negative linear associations between T2 and time from symptom onset in the
deltoid and supraspinatus, and between AFD and time from symptom onset in the supraspinatus
(Figure 2). Additionally, supraspinatus T2 vs. time from symptom onset appeared
to follow a nonlinear pattern and was fitted with a gamma distribution curve (shape=2, θ=136 days, r2
=0.316); supraspinatus volume (normalized to volume estimated at 136 days) vs. time was
fitted with a quadratic curve (r2 =0.197) (Figure 3). Discussion
This study
revealed significant associations between muscle volume, T2, and AFD that suggest
that qMRI biomarkers reflect the severity of muscle denervation and impairment
of muscle function in PTS. The associations between EMG MUR and T2 or AFD suggest
that qMRI biomarkers parallel muscle electrical activity. While shoulder
abduction function was strongly associated with qMRI of either the deltoid or
supraspinatus, these associations reveal that PTS involving both the
suprascapular and axillary nerves has a more severe impact on shoulder
abduction. There were fewer associations involving FF, which may be expected,
as many PTS patients do recover in 12-18 months.
This
study also elucidated important longitudinal patterns of decreased T2 and AFD with
time, reflecting reduced muscle edema but increased atrophy during recovery. Nonlinear
fitting of T2 may further characterize the initial increase in T2, peaking at approximately
200 days post symptom onset, followed by a more gradual recovery period.
Similarly, nonlinear fitting of supraspinatus volume shows an initial decrease and
eventual recovery of muscle bulk.
This
study was limited by relatively few data points in the early (<30 days) and
late (>400 days) timepoints, as well as variation between subjects. The data
are part of a larger, ongoing longitudinal PTS study, which includes other
commonly affected nerves in PTS, such as the long thoracic and anterior interosseous.
Conclusion
Analysis of qMRI biomarkers in denervated muscle in PTS reveal important
associations between individual qMRI biomarkers, associations with EMG and
muscle function, and changes with time.Acknowledgements
We would like to thank Drs Joeseph Feinberg and Carlo Milani for their contributions to the study (electromyography and physical exams) and Joseph Nguyen for useful discussions.References
1.
Alfen N van, Engelen BGM van. The clinical spectrum of neuralgic amyotrophy in
246 cases. Brain. 2006;129(2):438-450. doi:10.1093/brain/awh722
2.
Feinberg JH, Radecki J. Parsonage-Turner Syndrome. Hss J.
2010;6(2):199-205. doi:10.1007/s11420-010-9176-x
3.
Cup EH, Ijspeert J, Janssen RJ, et al. Residual Complaints After Neuralgic
Amyotrophy. Arch Phys Med Rehab. 2013;94(1):67-73.
doi:10.1016/j.apmr.2012.07.014
4.
Feinberg JH, Nguyen ET, Boachie‐Adjei K, et al. The electrodiagnostic natural
history of parsonage–turner syndrome. Muscle Nerve. 2017;56(4):737-743.
doi:10.1002/mus.25558
5.
Argentieri EC, Tan ET, Whang JS, et al. Quantitative T2‐mapping magnetic
resonance imaging for assessment of muscle motor unit recruitment patterns. Muscle
Nerve. 2021;63(5):703-709. doi:10.1002/mus.27186
6.
Tan ET, Zochowski KC, Sneag DB. Diffusion MRI fiber diameter for muscle
denervation assessment. Quant Imaging Med Surg. 2022;0(0):0-0.
doi:10.21037/qims-21-313
7.
Pons C, Borotikar B, Garetier M, et al. Quantifying skeletal muscle volume and
shape in humans using MRI: A systematic review of validity and reliability. PLoS
ONE. 2018;13(11):e0207847. doi:10.1371/journal.pone.0207847